Suppr超能文献

具有抑制P-糖蛋白作用的羟基喜树碱纳米混悬剂的药学评价

[Pharmaceutical evaluation of hydroxycamptothecin nanosuspensions with the action of inhibiting P-gp].

作者信息

Pu Xiao-Hui, Sun Jin, Qin Yi-Meng, Zhang Xiao, Zhang Peng, He Zhong-Gui

机构信息

Pharmaceutical College of Henan University, Kaifeng 475004, China.

出版信息

Yao Xue Xue Bao. 2011 Jul;46(7):834-8.

Abstract

Oral hydroxycamptothecin nanosuspension (HCPT-Nano) with high supersaturated dissolution level, high permeation and well physical stability, was manufactured by microprecipitation-high press homogenization method. Its pharmaceutical properties were investigated, such as size and distribution, zeta potential, particle shape, physical existence condition, supersaturated dissolution level and so on. Particle size was measured by laser diffraction, and the mean diameters before and after lyophilization were 138 +/- 11.72 nm and 175 +/- 12.74 nm, respectively, for HCPT-Nano. Zeta potentials of HCPT-Nano was over -20 mV. The nanoparticles, being observed by transmission electron microscopy (TEM), were claviform or column in shape. DSC and X-ray diffraction revealed that HCPT existed in the form of crystal for HCPT-Nano. And HCPT-Nano could maintain higher supersaturated dissolution level for long time. So it supplied the possibility of improving oral bioavailability of HCPT when combining together admoveatur of P-gp inhibitor, CsA.

摘要

采用微沉淀-高压均质法制备了具有高过饱和溶解水平、高渗透性和良好物理稳定性的口服羟基喜树碱纳米混悬剂(HCPT-Nano)。研究了其药学性质,如粒径及分布、ζ电位、颗粒形状、物理存在状态、过饱和溶解水平等。通过激光衍射法测定粒径,HCPT-Nano冻干前后的平均直径分别为138±11.72nm和175±12.74nm。HCPT-Nano的ζ电位超过-20mV。通过透射电子显微镜(TEM)观察到纳米颗粒呈棒状或柱状。差示扫描量热法(DSC)和X射线衍射表明,HCPT-Nano中的HCPT以晶体形式存在。并且HCPT-Nano能够长时间保持较高的过饱和溶解水平。因此,当与P-糖蛋白抑制剂环孢素(CsA)联合给药时,为提高HCPT的口服生物利用度提供了可能性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验